Astrocytoma in a breast cancer lineage: part of the BRCA2 phenotype?
Wilson
Brian T
BT
Northern Genetics Service, Institute of Human Genetics, International Centre for Life, Newcastle upon Tyne, United Kingdom.
Douglas
S Fiona
SF
Polvikoski
Tuomo
T
D000328:Adult; D051017:Apoptosis Regulatory Proteins; D001254:Astrocytoma / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D024682:BRCA2 Protein / Q000235:genetics*; D001932:Brain Neoplasms / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D003399:Craniotomy; D004252:DNA Mutational Analysis; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D020022:Genetic Predisposition to Disease; D005838:Genotype; D040941:Heredity; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009154:Mutation; D010375:Pedigree; D010641:Phenotype; D018714:Radiotherapy, Adjuvant; D016896:Treatment Outcome
D051017:Apoptosis Regulatory Proteins; C118024:BLID protein, human; D024682:BRCA2 Protein; C551750:BRCA2 protein, human